DuPont announced financial results for the first quarter ended March 31, 2025. Net sales totaled $3.1 billion, up 5% compared to the prior-year period, with organic sales increasing 6% driven by volume growth in electronics, healthcare, and water end-markets.

The company reported a GAAP loss from continuing operations of $548 million, or $(1.33) per share, primarily due to a $768 million non-cash goodwill impairment charge related to the realignment of its Aramids reporting unit. Adjusted earnings per share (EPS) were $1.03.

Operating EBITDA rose 16% to $788 million, with margin expansion to 25.7%. ElectronicsCo delivered 14% organic sales growth and a 26% increase in operating EBITDA, supported by strong demand in semiconductor technologies and AI-related applications. IndustrialsCo posted 2% organic sales growth with volume gains in healthcare and water, and operating EBITDA increased 6%.

DuPont reaffirmed its full-year 2025 guidance, projecting net sales between $12.8 billion and $12.9 billion and adjusted EPS between $4.30 and $4.40. Guidance does not include the estimated $60 million net cost impact of recently announced tariffs.

Learn more: https://www.dupont.com